HDAC6 and neoplasm: For instance, HDAC6 recruited and activated STAT3, enabling an upregulation of PD-L1, and the treatment of HDAC6 specific-inhibitors leads to retard tumor growth and downmodulate PD-L1 expression in vivo [25].